FDA Inspection
Hiers Enterprises, LLC dba Northwest Compounding PharmacyHiers Enterprises, LLC dba Northwest Compounding Pharmacy – FDA Inspection, Nov 10, 2021
Record Details
This FDA Inspection record concerns Hiers Enterprises, LLC dba Northwest Compounding Pharmacy, with an inspection on November 10, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 10, 2021
- Product Type
- Drugs
View Company Profile
ID · f450e145-da59-40fd-beff-1e596359e90a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1157204
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- State Referral Letter
FDA Citations
3- Personnel habits, contamination
- Beta-lactam drugs, inadequate sanitation
- Hazardous drugs, prevention of cross-contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 14, 2018 | Not classified | Seattle District Office | Drug Quality Assurance |
Other documents for Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
- FDA Inspection 1173041 - 2022-06-16
- FDA Inspection 1071602 - 2018-11-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.